about
Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986Inhibiting bladder tumor growth with a cell penetrating R11 peptide derived from the p53 C-terminus.Immunotherapy for urothelial carcinoma: current status and perspectives.Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Evidence-based management of cancer in the elderly.
@ast
Evidence-based management of cancer in the elderly.
@en
type
label
Evidence-based management of cancer in the elderly.
@ast
Evidence-based management of cancer in the elderly.
@en
prefLabel
Evidence-based management of cancer in the elderly.
@ast
Evidence-based management of cancer in the elderly.
@en
P2860
P1433
P1476
Evidence-based management of cancer in the elderly.
@en
P2093
Balducci L
P2860
P304
P356
10.1177/107327480000700412
P577
2000-07-01T00:00:00Z